Impact of age on outcome of patients with cancer undergoing autologous bone marrow transplant

Journal of Clinical Oncology

Volumn 14, Issue 4, 1996, Pages 1327-1332

  Miller, C B ^a   Piantadosi, S ^a   Vogelsang, G B ^a   Marcellus, D C ^a   Grochow, L ^a   Kennedy, M J ^a   Jones, R J ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; ETOPOSIDE; TIOGUANINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; AGING; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BREAST CARCINOMA; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL PROTOCOL; HODGKIN DISEASE; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

EID: 0029912401     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.4.1327     Document Type: Article

References (32)

1. Wingo PA, Tong T, Bolden S: Cancer statistics, 1995. CA 45:8-30, 1995
2. Blume KG, Forman SJ, Nademanee AP, et al: Bone marrow transplantation for hematologic malignancies in patients aged 30 years or older. J Clin Oncology 4:1489-1492, 1986
3. De Witte T, Bar BM, Schattenberg A, et al: Favourable outcome of patients older than 49 years of age after transplantation with marrow grafts depleted of lymphocytes by counterflow centrifugation. Br J Haematol 74:53-60, 1990
4. Klingemann HG, Storb R, Fefer A, et al: Bone marrow transplantation in patients aged 45 years and older. Blood 67:770-776, 1986
5. Beelen DW, Quabeck K, Mahmoud HK, et al: Allogeneic bone marrow transplantation for acute leukaemia or chronic myeloid leukaemia in the fifth decade of life. Eur J Cancer Clin Oncol 23:1665-1671, 1987
6. Cahn JY, Labopin M, Mandelli F, et al: Autologous bone marrow transplantation for first remission acute myeloblastic leukemia in patients older than 50 years: A retrospective analysis of the European bone marrow transplant group. Blood 85:575-579, 1995
7. Jones RJ, Lee KSK, Beschorner WE, et al: Venoocclusive disease of the liver following bone marrow transplantation. Transplantation 44:778-783, 1987
8. Wingard JR, Sostrin MB, Vriesendorp HM, et al: Interstitial pneumonitis following autologous bone marrow transplantation. Transplantation 46:61-65, 1988
9. Pecego R, Hill R, Appelbaum FR, et al: Interstitial pneumonitis following autologous bone marrow transplantation. Transplantation 42:515-517, 1986
10. Davis JM, Rowley SD, Piantadosi S, et al: Graft failure after 4-hydroperoxycyclophosphamide (4HC) -purged autologous bone marrow transplantation (ABMT). Blood 80:376a, 1992 (suppl 1, abstr)
11. McDonald GB, Hinds MS, Fisher LD, et al: Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients. Ann Intern Med 118:255-267, 1993
12. Crilley P, Topolsky D, Styler MJ, et al: Extramedullary toxicity of a conditioning regimen containing busulphan, cyclophosphamide and etoposide in 84 patients undergoing autologus and allogeneic bone marrow transplantation. Bone Marrow Transplant 15:361-365, 1995
13. Nevill TJ, Barnett MJ, Klingemann H-G, et al: Regimen-related toxicity of a busulfan-cyclophosphamide conditioning regimen in 70 patients undergoing allogeneic bone marrow transplantation. J Clin Oncology 9:1224-1232, 1991
14. Karp JE, Dick JE, Merz WG: Systemic infection and colonization with and without prophylactic norfloxacin use over time in the granulocytopenic, acute leukemia patient. Eur J Cancer Clin Oncol 24:S5-S13, 1988 (suppl 1)
15. Karp JE, Dick JD, Angelopulos C, et al: Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Am J Med 81:237-242, 1986
16. Saral R, Ambinder RF, Burns WH, et al: Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. Ann Intern Med 99:773-776, 1983
17. Goodman JL, Winston DJ, Greenfield RA, et al: A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 326:845-851, 1992
18. Wingard JR, Merz WG, Rinaldi MG, et al: Increase in candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 325:1274-1277, 1991
19. Wingard JR, Vaughan WP, Braine HG, et al: Prevention of fungal sepsis in patients with prolonged neutropenia: A randomized, double-blind, placebo-controlled trial of intravenous miconazole. Am J Med 83:1103-1106, 1987
20. Yeager AM, Kaizer H, Santos GW, et al: Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. N Engl J Med 315:141-147, 1986
21. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
22. Cockcroft DW, Gault MH: Predictions of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
23. Cox DR: Regression models and life tables (with discussion). J R Stat Soc 34:187-220, 1972
24. Wilcoxon F: Individual comparisons by ranking methods. Biometrics 1:80-83, 1945
25. Grochow LB, Jones RJ, Brundrett RB, et al: Pharmacokinetics of busulfan: Correlation with veno-occlusive disease in patients undergoing bone marrow transplantation. Cancer Chemother Pharmacol 25:55-61, 1989
26. Gelman RS, Taylor SG: Cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in women more than 65 years old with advanced breast cancer: The elimination of age trends in toxicity by using doses based on creatinine clearance. J Clin Oncology 2:1404-1413, 1984
27. Dawling S, Crome P: Clinical pharmacokinetic considerations in the elderly. Clin Pharmacokinet 17:236-263, 1989
28. Montamat SC, Cusack BJ, Vestal RE: Management of drug therapy in the elderly. N Engl J Med 321:303-309, 1989
29. Grochow LB, Jones RJ, Brundrett RB, et al: Pharmacokinetics of busulfan: Correlation with veno-occlusive disease in patients undergoing bone marrow transplantation. Cancer Chemother Pharmacol 25:55-61, 1989
30. Crump M, Smith AM, Brandwein J, et al: High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: Importance of disease status at transplant. J Clin Oncology 11:704-711, 1993
31. Armitage JO, Bierman PJ, Vose JM, et al: Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease. Am J Med 91:605-611, 1991
32. Jagannath S, Barlogie B, Dicke K, et al: Autologous bone marrow transplantation in multiple myeloma: Identification of prognostic factors. Blood 76:1860-1866, 1990